Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,099 | 10,879 | 9,224 | 7,763 | 0 |
| Other current assets | 0 | 0 | 0 | 168 | 0 |
| TOTAL | $12,422 | $11,201 | $9,556 | $8,286 | $0 |
| Non-Current Assets | |||||
| PPE Net | 720 | 773 | 802 | 1,172 | N/A |
| Intangibles | 419 | 403 | 399 | 400 | 0 |
| TOTAL | $1,139 | $1,176 | $1,202 | $1,572 | $N/A |
| Total Assets | $13,561 | $12,377 | $10,758 | $9,859 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 965 | 808 | 543 | 789 | 0 |
| Accrued Expenses | 48 | 94 | 27 | 21 | 0 |
| Other current liabilities | 160 | 89 | 18 | N/A | 0 |
| TOTAL | $1,173 | $991 | $587 | $810 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,173 | $991 | $587 | $810 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,164 | 2,099 | 2,104 | 2,030 | N/A |
| Common Shares | 150 | 146 | 144 | 142 | 0 |
| Retained earnings | -25,748 | -24,357 | -23,217 | -21,959 | 0 |
| Other shareholders' equity | 8 | 8 | 8 | 8 | 0 |
| TOTAL | $12,388 | $11,386 | $10,171 | $9,049 | $0 |
| Total Liabilities And Equity | $13,561 | $12,377 | $10,758 | $9,859 | $0 |